AquaVita NextGen review

Compare the purchase in the supply period actually listed

AquaVita lists semaglutide at $215 for one month and $600 for three months; tirzepatide is $320 and $900 respectively. The one-month semaglutide and three-month tirzepatide product pages show the corresponding totals. These are distinct supply purchases, not a single monthly charge that applies to every plan. ^{[1] [2] [3]}

Confirm the actual amount due, prescription preparation and supplied calendar. A three-month description does not establish ninety days, the number of vials or installment billing. Product instructions place payment before the provider meeting, so include the assessment and non-approval terms in the comparison rather than equating an order confirmation with clinical eligibility.

Compare total payments and supply periods with the complete GLP-1 cost planner.

For a different concierge-led care and payment agreement, compare our Tonik service-and-commitment review.

Provider access is a strength when follow-up is usable

The expanded FAQ advertises unlimited access to licensed providers, follow-ups and adjustments. The service describes a telehealth examination before prescribing and lists Arizona, California, Florida, Nevada and Texas. That gives a reader a real service scope to compare, with current prescription-specific availability still needing confirmation. ^{[4] [5]}

The terms distinguish independent clinical and pharmacy services from the platform. Establish who receives symptom questions, how follow-ups are arranged and which monitoring costs are included. Unlimited access does not establish a particular response time, scheduled nutrition visits or a test panel in every purchase. ^[6]

Separate clinical review and pharmacy fulfillment in our clinic-versus-pharmacy-access comparison.

The refill and refund rules depend on the actual agreement

For products sold on auto-renewal, terms require cancellation at least two days before processing. They permit an early first renewal, end cancellation at the paid period’s boundary and exclude partial-period refunds. Confirm whether the selected product recurs and its actual processing date; the catalogue alone does not answer that. ^[6]

The return policy asks for damaged, missing or incorrect deliveries to be reported within forty-eight hours and permits an approved replacement or refund to the original payment method. Purchase terms instead describe discretionary store-credit refunds and final sales. Settle the applicable rule before payment, including what happens if the clinician declines treatment. ^{[7] [8]}

For another billing and clinical-support arrangement, read our Joi + Blokes quarterly-plan review.

The branded and compounded products remain different

The product pages label the medicines compounded and not FDA-approved. A separate FAQ introduction’s reference to FDA-approved medications does not change that product identity. Neither a familiar ingredient name nor a pharmacy-regulation statement transfers a branded drug’s approval or trial results to this prescription. ^{[2] [3] [4] [9]}

FDA’s current policy describes conditions for compounding after the injection shortages were resolved. The actual patient need and preparation belong with the prescriber and dispenser. Compare the documented purchase and care model without turning lower cost or a customization claim into a clinical or regulatory exemption. ^[10]

Keep trial products and populations explicit in the semaglutide-versus-tirzepatide research.

Understanding the cost

Catalogue: one-month semaglutide $215/tirzepatide $320; three-month semaglutide $600/tirzepatide $900. These are stated supply prices, not established installment amounts. Confirm invoice, actual preparation, supply calendar, renewal and the assessment/non-approval charge.